Related Experiment Videos
Insights
Hypolipidemias, or low lipid levels, are rare primary conditions or secondary to other diseases. This review focuses on secondary hypolipidemias linked to malabsorption, liver and endocrine disorders, and specific autoimmune conditions.
Area of Science:
- Lipid Metabolism and Cardiovascular Health
Background:
- Hypolipidemias encompass primary (rare familial forms like abetalipoproteinemia) and secondary (symptomatic) types.
- Severe hypolipidemia can occur in specific populations, such as the Masai people.
- Understanding hypolipidemia is crucial for diagnosing and managing associated health conditions.
Purpose of the Study:
- To provide a comprehensive overview of hypolipidemia, differentiating between primary and secondary forms.
- To detail the various causes and clinical associations of secondary hypolipidemias.
- To review less common causes, including autoantibodies against lipoproteins.
Main Methods:
- Literature review and synthesis of existing research on hypolipidemias.
- Classification of hypolipidemias into primary and secondary categories.
- Discussion of clinical conditions associated with each type of hypolipidemia.
Main Results:
- Primary hypolipidemias (abetalipoproteinemia, hypobetalipoproteinemia, analphalipoproteinemia) are exceedingly rare.
- Secondary hypolipidemias are more common and associated with malabsorption, malnutrition, maldigestion (e.g., protein-losing gastroenteropathy), liver diseases, and endocrine disorders (hyperthyroidism, hirsutism).
- Autoantibodies against high-density lipoprotein (HDL) and low-density lipoprotein (LDL) can also lead to secondary hypolipidemia in conditions like M-gradient, carcinoma, and rheumatoid arthritis.
Conclusions:
- Secondary hypolipidemias are clinically significant and linked to a wide range of underlying pathologies.
- Recognition of secondary hypolipidemia is essential for identifying and treating associated diseases.
- Further research into autoimmune-mediated hypolipidemias may reveal new diagnostic and therapeutic targets.
Abstract:
Hypolipidemias can be divided in primary, familial and hereditary forms and symptomatic forms which may accompany other diseases. The primary hypolipidemias (abetalipoproteinemia, hypobetalipoproteinemia and analphalipoproteinemia) are very rare. Severe hypolipidemia can be found in some peoples (e.g. the Masai). This article is chiefly devoted to secondary hypolipidemias such as those associated with malabsorption, malnutrition and maldigestion including protein-losing gastroenteropathy, with liver diseases, endocrine diseases (hyperthyroidism, hirsutism) and anemia. Finally, the hypolipidemias secondary to the formation of autoantibodies against HDL and LDL in M-gradient, carcinoma and rheumatoid arthritis are briefly reviewed.